Hematology News

Low-dose aspirin use was significantly associated with an increased risk for anemia among older Danish adults in a real-world setting, according to a study published in European Heart Journal – Quality of Care and Clinical Outcomes.

Stroke rates among individuals with sickle cell disease have increased steadily over the last 25 years despite guidelines aimed at prevention, according to results of a retrospective study.

For pregnant women on bed rest, a foam roller intervention improved lower limb venous blood flow compared with controls, mitigating deep vein thrombosis risk and muscle atrophy, researchers reported.

The FDA approved marstacimab-hncq for treatment of certain individuals with hemophilia.

Patient readiness will greatly affect the success of gene therapy for sickle cell disease at the individual and collective levels, according to a consensus statement published in JAMA Network Open.

Patients with sickle cell disease who had non-myeloablative hematopoietic cell transplants had similar or better lung function 3 years later, according to results published in Annals of the American Thoracic Society.

ASH has announced its three inaugural quality improvement champions.

Healio spoke with Naval Daver, MD, about presentations on the use of molecular therapies, including menin inhibitors, in the treatment of acute myeloid leukemia from Society of Hematologic Oncology Annual Meeting.

September is National Sickle Cell Awareness Month.